With the price closing at 2.3p (17th April 2012), a clear breakout is evident!
Looking into this, it seems as though this Company is really staring to get its act together, as witnessed by the recent newsflow:
- Pre-Close Statement (30th March 2012)
- Science in Sport Update (12th March 2012)
- Fruitflow Update (14th February 2012)
Looking at the newsflow, the interest in cycling in this (Olympic) year, the TA (rising OBV, RSI etc) - I can't help wondering if PXS is starting a recovery in the share price could bring rewards for us DIY-Investors?
Usual caveats about DYOR etc...
This is a complete act of faith - I've been undone before by blue sky concepts for bio/health.
ReplyDeleteWhat experience and commercial success have the management had previously? The CE's name doesn't inspire much confidence!
You must be kidding, this is a fantastic company and plum to buy with fruitflow & Science in Spirt they can't go wrong . Great entry opportunity before significant European dietary player announced taking fruitflow . Strong Buy
ReplyDeleteOne of the aspects that many people with heart related problems will have, particularly if they have had a stent fitted, is that they will have been prescribed drugs like Clopidogrel - which they normally come off after 1 year. They will also probably be taking aspirin, which can have (for some) some side effects. The posibility of fruitflow additive as an 'insurance' for these people shouldn't (IMO) be ignored.
ReplyDelete